Seller record · Telehealth service

Voxy

By Paul Harris, Standards EditorRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S4, compounding disclosure: No page states that the compounded products are not FDA-approved. The treatment pages and footer say only that compounded medications are not reviewed by the FDA for safety or efficacy, and the semaglutide page calls compounded semaglutide the clinically proven GLP-1 medication. 1 more criterion also fails; see the table below.

At a glance

VoxyTelehealth service

6/8criteria passed

Price: Compounded semaglutide from $99 a month on the 12-month plan, or $175 month to month; tirzepatide from $135
Sells: compounded semaglutide, compounded tirzepatide, NAD+, and 2 more
FDA letters: None on file

Visit Voxy See all eight dispositions

Telehealth service. Passes 6 of 8 criteria. Recorded against Standard v1.1.

A Scottsdale telehealth practice selling compounded semaglutide and tirzepatide memberships, beside NAD+, sermorelin and glutathione. Care comes from a named outside medical group after a free assessment, and medication comes from a named Houston pharmacy.

Operating entity No legal entity name appears in the footer, on the compliance page or in the privacy notice, which name the company only as Voxy Health, and the site carries no terms page.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Voxy's compliance page; Voxy's about page; Voxy's how it works page
S2	Prescription gating	PASS	Voxy's website; Voxy's semaglutide page; Voxy's how it works page
S3	Pharmacy identification	PASS	Voxy's compliance page
S4	Compounding disclosure	FAIL	Voxy's semaglutide page; Voxy's tirzepatide page; Voxy's website
S5	Analytical documentation	FAIL	Voxy's semaglutide page; Voxy's sermorelin page
S6	Business address	PASS	Voxy's website; Voxy's privacy policy
S7	Price disclosure	PASS	Voxy's semaglutide page; Voxy's tirzepatide page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed nurse practitioner reviews each intake or consultation and designs a treatment only if it is appropriate. The compliance page names Arora Health & Aesthetics, LLC in Seattle as the medical provider group.Source: Voxy's compliance page; Voxy's about page; Voxy's how it works page.

S2PASSThe home and treatment pages describe a free assessment or consultation first, in which a licensed provider reviews the health history and decides whether treatment is right, then a treatment plan and shipping from the pharmacy.Source: Voxy's website; Voxy's semaglutide page; Voxy's how it works page.

S3PASSThe compliance page names the partner pharmacy that prepares and fills prescriptions: VialsRX, 6220 Westpark Dr, Houston, TX 77057.Source: Voxy's compliance page.

S4FAILNo page states that the compounded products are not FDA-approved. The treatment pages and footer say only that compounded medications are not reviewed by the FDA for safety or efficacy, and the semaglutide page calls compounded semaglutide the clinically proven GLP-1 medication.Source: Voxy's semaglutide page; Voxy's tirzepatide page; Voxy's website.

S5FAILNo certificate of analysis or lot document is published. The treatment pages show potency, sterility, endotoxin and pH results marked passed for every batch, with no report behind them.Source: Voxy's semaglutide page; Voxy's sermorelin page.

S6PASSVoxy Health at 8350 E Raintree Dr Ste 245, Scottsdale, AZ 85260, printed in the footer of every page and in the privacy notice.Source: Voxy's website; Voxy's privacy policy.

S7PASSCompounded semaglutide costs $175 a month month to month, $145 a month on the 3-month plan, $120 on the 6-month plan and $99 on the 12-month plan; compounded tirzepatide costs $225, $199, $175 and $135 a month on the same plans, with the provider visit, medication and shipping included. The NAD+, sermorelin and glutathione pages print no price.Source: Voxy's semaglutide page; Voxy's tirzepatide page.

S8PASSNo FDA warning letter names Voxy or Voxy Health, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, NAD+, sermorelin, glutathione.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+Who sells glutathione

Visit Voxy

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.